statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Deep Dive Into Globus Medical Stock: Analyst Perspectives (7 Ratings)

Latest Ratings for GMED
 DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Feb 2022Credit SuisseMaintainsOutperform Feb 2022NeedhamMaintainsBuy
 View More Analyst Ratings for...

Key Takeaways From Globus Medical Analyst Ratings

Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results

Globus Medical reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32% and represents a 35.85% increase over earnings from the same period...

Q2 2024 EPS Estimates for Globus Medical, Inc. (NYSE:GMED) Raised by Zacks Research

Globus Medical, Inc. (NYSE:GMED - Free Report) - Equities researchers at Zacks Research raised their Q2 2024 earnings per share (EPS) estimates for Globus Medical in a research note issued to...

Globus Medical (GMED, $53.13) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 1, 2024

This is a Bullish indicator signaling GMED's price could rise from here. Traders may explore going long the stock or buying call options...

Washington Capital Management Inc. Invests $554,000 in Globus Medical, Inc. (NYSE:GMED)

Washington Capital Management Inc. purchased a new position in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) in the 4th quarter, according to the company in its most recent filing with...

Globus Medical, Inc. (NYSE:GMED) Receives Average Recommendation of "Moderate Buy" from Brokerages

Globus Medical, Inc. (NYSE:GMED  Get Free Report) has received a consensus rating of Moderate Buy from the nine research firms that are currently covering the company...

Globus Medical (NYSE:GMED) Shares Gap Up to $51.40

Globus Medical, Inc. (NYSE:GMED  Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $51.40, but opened at $53.47. Globus Medical shares last...

Globus Medical (GMED, $51.87) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 14, 2024

This is a Bearish indicator signaling GMED's price could decline from here. Traders may explore shorting the stock or put options...

Globus Medical (GMED) Shares Cross Below 200 DMA

In trading on Thursday, shares of Globus Medical Inc (GMED) crossed below their 200 day moving average of 53.31, changing hands as low as 51.21 per share. Globus Medical Inc shares are...

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

Volume	786,116.00
52-Wk High	$74.16
52-Wk Low	$43.39

GMED Globus Medical Inc

About

Feed

News

Sentiment

Earnings

Fundamentals